Purchase of Own Securities

UNITED DRUG PLC

('United Drug' or 'the Company')

Purchase of Own Securities

United Drug announces that on 17 June 2011, its broker Davy purchased 60,862 Ordinary Shares of nominal value €0.05 each in the capital of the Company ("Ordinary Shares") on behalf of the Company. The price paid for these Ordinary Shares was €2.281 per share.

The 60,862 Ordinary Shares will be cancelled. Following the cancellation of these shares, the Company's issued share capital will reduce from 242,247,683 to 242,186,821. Each Ordinary Share carries one vote. United Drug also holds 7,528,066 Ordinary Shares in treasury, which do not carry voting rights. 

Ends 20 June 2011

Contact:

Karen Geoghegan

United Drug plc

Tel: +353-1-4637720